TrialBMC psychiatry2020

The safety and efficacy of transcranial direct current stimulation as add-on therapy to fluoxetine in obsessive-compulsive disorder: a randomized, double-blind, sham-controlled, clinical trial.

Sadegh Yoosefee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.